October 29, 2025
Discover key takeaways from HLTH 2025 including a video from Pleio CEO Michael Oleksiw. Learn how Pleio is using AI to uncover emotional barriers and empower people, not replace them, in creating a more human patient experience.
October 28, 2025
In an interview with Pharmaceutical Commerce, Jen Butler, CCO of Pleio, noted that while DTC drug models expand access, they often leave patients without the guidance and connection needed for safe, consistent use. She emphasized that true adherence requires pairing digital convenience with human conversation and clinical oversight.
October 1, 2025
Pleio CEO Michael Oleksiw appears on Planetary Health First, Mars Next to explore how tackling loneliness is key to better health outcomes. He reveals how Pleio’s human-first approach helps patients stay on therapy by addressing emotional barriers that technology alone can’t solve.
September 24, 2025
As part of Fierce Pharma Marketing’s Rising Stars series, Pleio Marketing Manager Madison Norman discusses why empathy should lead the way in health tech. She explores how balancing innovation with human understanding can drive more meaningful patient experiences.
October 21, 2025
Specialty drug access challenges go beyond cost and paperwork. In Pharmaceutical Commerce, CoverMyMeds’ Megan Wetzel and Pleio’s Jen Butler discuss how prior authorization delays, affordability barriers, and patient loneliness together undermine adherence—and why restoring connection is key to better outcomes.
October 21, 2025
Chronic loneliness is sabotaging chronic care. In this HIT Consultant byline, Pleio CEO Michael Oleksiw explains why digital tools alone can’t fix adherence—and why human connection must lead.
FOR MEDIA INQUIRIES PLEASE EMAIL media@pleio.com.